UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16155) 16155
Newsletter (110) 110
Book Chapter (106) 106
Dissertation (32) 32
Magazine Article (32) 32
Publication (31) 31
Conference Proceeding (27) 27
Book / eBook (13) 13
Web Resource (7) 7
Newspaper Article (6) 6
Government Document (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12255) 12255
science & technology (8438) 8438
life sciences & biomedicine (8049) 8049
female (5555) 5555
male (5546) 5546
middle aged (3461) 3461
adult (3455) 3455
animals (3138) 3138
cardiovascular system & cardiology (2807) 2807
aged (2693) 2693
hematology (2611) 2611
antithrombin iii (2285) 2285
antithrombin iii - analysis (2116) 2116
antithrombin iii - metabolism (2098) 2098
peripheral vascular disease (1953) 1953
antithrombin (1950) 1950
abridged index medicus (1777) 1777
thrombin (1724) 1724
antithrombins - therapeutic use (1689) 1689
anticoagulants (1450) 1450
heparin (1386) 1386
blood coagulation (1224) 1224
anticoagulants - therapeutic use (1203) 1203
antithrombins - pharmacology (1197) 1197
blood coagulation - drug effects (1139) 1139
risk factors (1131) 1131
cardiac & cardiovascular systems (1104) 1104
thrombin - metabolism (1058) 1058
thrombosis (1050) 1050
heparin - pharmacology (1043) 1043
adolescent (1031) 1031
antithrombins (954) 954
antithrombins - metabolism (905) 905
biochemistry & molecular biology (895) 895
antithrombin iii deficiency (893) 893
blood coagulation tests (886) 886
fibrinolysis (876) 876
antithrombins - administration & dosage (872) 872
time factors (860) 860
treatment outcome (853) 853
antithrombins - adverse effects (842) 842
thrombin - antagonists & inhibitors (833) 833
aged, 80 and over (825) 825
heparin - therapeutic use (815) 815
coagulation (804) 804
kinetics (795) 795
dabigatran (794) 794
general & internal medicine (790) 790
pregnancy (771) 771
rats (698) 698
protein c (693) 693
pharmacology & pharmacy (679) 679
prospective studies (670) 670
surgery (665) 665
heparin - metabolism (631) 631
anticoagulants - pharmacology (619) 619
analysis (617) 617
binding sites (616) 616
partial thromboplastin time (612) 612
antithrombin iii - pharmacology (603) 603
protein binding (599) 599
antithrombins - chemistry (596) 596
anticoagulants - administration & dosage (588) 588
dose-response relationship, drug (584) 584
molecular sequence data (582) 582
child (580) 580
fibrinogen - analysis (577) 577
anticoagulants - adverse effects (576) 576
antithrombins - analysis (569) 569
hemostasis (566) 566
hemorrhage - chemically induced (564) 564
fibrinogen - metabolism (563) 563
peptide hydrolases - analysis (553) 553
antithrombin iii - therapeutic use (524) 524
medicine, general & internal (519) 519
antithrombin iii - genetics (516) 516
recombinant proteins - therapeutic use (511) 511
amino acid sequence (506) 506
fibrin fibrinogen degradation products - analysis (497) 497
thromboembolism (492) 492
thrombosis - etiology (492) 492
heparin - administration & dosage (481) 481
factor xa inhibitors (475) 475
chemistry (464) 464
administration, oral (463) 463
beta-alanine - analogs & derivatives (463) 463
biomarkers - blood (456) 456
research (446) 446
proteins (442) 442
mutation (441) 441
fibrinogen (438) 438
rabbits (433) 433
atrial fibrillation - drug therapy (428) 428
protein s (428) 428
prothrombin time (428) 428
thrombosis - blood (428) 428
atrial fibrillation (423) 423
retrospective studies (422) 422
peptide hydrolases - blood (421) 421
protein c - metabolism (418) 418
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (6) 6
Online Resources - Online (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Theses (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
University Archives - Archives (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (14712) 14712
Japanese (654) 654
German (520) 520
French (311) 311
Russian (249) 249
Italian (125) 125
Polish (125) 125
Chinese (119) 119
Spanish (96) 96
Czech (36) 36
Danish (28) 28
Hungarian (26) 26
Korean (26) 26
Portuguese (20) 20
Norwegian (19) 19
Swedish (15) 15
Ukrainian (13) 13
Bulgarian (11) 11
Dutch (8) 8
Croatian (7) 7
Serbian (6) 6
Turkish (6) 6
Slovak (5) 5
Romanian (4) 4
Finnish (3) 3
Persian (2) 2
Arabic (1) 1
Hebrew (1) 1
Indonesian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation (New York, N.Y.), ISSN 1524-4539, 02/2014, Volume 129, Issue 7, pp. 764 - 772
Dabigatran and warfarin have been compared for the treatment of acute venous thromboembolism (VTE) in a previous trial. We undertook this study to extend those... 
Antagonists & inhibitors | Recurrence | Thrombin | Warfarin | Hemorrhage | Venous thromboembolism | Cardiac & Cardiovascular Systems | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Anticoagulants - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Heparin - administration & dosage | Heparin, Low-Molecular-Weight - adverse effects | Warfarin - adverse effects | Male | Antithrombins - administration & dosage | Dabigatran | Heparin - adverse effects | Warfarin - administration & dosage | Venous Thromboembolism - drug therapy | Young Adult | Benzimidazoles - administration & dosage | Adult | Female | Benzimidazoles - adverse effects | Venous Thromboembolism - epidemiology | beta-Alanine - analogs & derivatives | Acute Disease | beta-Alanine - adverse effects | Double-Blind Method | Hemorrhage - epidemiology | Risk Factors | beta-Alanine - administration & dosage | Anticoagulants - adverse effects | Antithrombins - adverse effects | Adolescent | Aged | Hemorrhage - chemically induced | Heparin, Low-Molecular-Weight - administration & dosage | Usage | Care and treatment | Dabigatran etexilate | Thromboembolism | Index Medicus | Abridged Index Medicus | Anticoagulants | Benzimidazoles | Heparin, Low-Molecular-Weight | Life Sciences | Venous Thromboembolism | Antithrombins | Heparin | beta-Alanine
Journal Article
Journal Article
Annals of hematology, ISSN 1432-0584, 09/2013, Volume 93, Issue 3, pp. 385 - 392
Antithrombin (AT) deficiency is a rare hereditary thrombophilia with a mean prevalence of 0.02 % in the general population, associated with a more than... 
Pregnancy | Medicine & Public Health | Hematology | Maternal outcome | Antithrombin deficiency | Oncology | Low molecular weight heparin | Miscarriage | Fetal outcome | Venous thromboembolism | Life Sciences & Biomedicine | Science & Technology | Pre-Eclampsia - epidemiology | Fetal Death - etiology | Pregnancy Complications - blood | Abortion, Habitual - epidemiology | Humans | Heparin, Low-Molecular-Weight - adverse effects | Heparin - therapeutic use | Antithrombin III Deficiency - genetics | Antithrombin III Deficiency - blood | Heparin - adverse effects | Heparin, Low-Molecular-Weight - therapeutic use | Young Adult | Pre-Eclampsia - prevention & control | Venous Thromboembolism - prevention & control | Drug Therapy, Combination - adverse effects | Antithrombin III Deficiency - physiopathology | Fetal Growth Retardation - etiology | Adult | Female | Abortion, Habitual - prevention & control | Retrospective Studies | Abortion, Habitual - etiology | Venous Thromboembolism - epidemiology | Antithrombin III - adverse effects | Antithrombin III - analysis | Risk Factors | Fetal Growth Retardation - epidemiology | Hospitals, University | Antithrombin III - therapeutic use | Fetal Growth Retardation - prevention & control | Anticoagulants - therapeutic use | Pregnancy Complications - physiopathology | Anticoagulants - adverse effects | Pre-Eclampsia - etiology | Fetal Death - prevention & control | Germany - epidemiology | Pregnancy Complications - drug therapy | Venous Thromboembolism - etiology | Fetal Death - epidemiology | Antithrombin III Deficiency - drug therapy | Pregnancy Complications - genetics | Mutation | Prevention | Women | Nervous system diseases | Pregnant women | Analysis | Patient outcomes | Infants | Thromboembolism | Health aspects | Index Medicus
Journal Article
Journal of thrombosis and haemostasis, ISSN 1538-7933, 09/2018, Volume 16, Issue 9, pp. 1891 - 1894
Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Recurrence | Pulmonary Embolism - prevention & control | Pyrazoles - therapeutic use | Dabigatran - administration & dosage | Prospective Studies | Anticoagulants - administration & dosage | Humans | Thiazoles - administration & dosage | Antithrombins - administration & dosage | Thiazoles - therapeutic use | Dabigatran - therapeutic use | Rivaroxaban - administration & dosage | Venous Thromboembolism - drug therapy | Factor Xa Inhibitors - administration & dosage | Neoplasms - complications | Pyridones - administration & dosage | Venous Thromboembolism - prevention & control | Multicenter Studies as Topic | Neoplasms - blood | Dalteparin - therapeutic use | Observational Studies as Topic | Venous Thrombosis - prevention & control | Rivaroxaban - therapeutic use | Pyridines - therapeutic use | Pyridines - administration & dosage | Venous Thrombosis - drug therapy | Administration, Oral | Antithrombins - therapeutic use | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Venous Thrombosis - etiology | Randomized Controlled Trials as Topic | Venous Thromboembolism - etiology | Factor Xa Inhibitors - therapeutic use | Pyrazoles - administration & dosage | Patient Acceptance of Health Care | Pulmonary Embolism - etiology | Antithrombins - adverse effects | Factor Xa Inhibitors - adverse effects | Pulmonary Embolism - drug therapy | Pyridones - therapeutic use | Hemorrhage - chemically induced | Care and treatment | Anticoagulants (Medicine) | Thromboembolism | Drug therapy | Cancer | Anticoagulants | Index Medicus
Journal Article